ArticleBlood advances2023
Posttransplant MRD and T-cell chimerism status predict outcomes in patients who received allografts for AML/MDS.
Justin Loke et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
30 papers cite it
this paperpooled itcites it